EUCTR2006-000390-30-FI进行中（未招募）不适用
A phase II trial assessing dapsone topical gel in the prevention and treatment of erlotinib associated rash
Helsinki University Central Hospital, Skin and Allergy Hospital0 个研究点目标入组 30 人开始时间: 2006年3月30日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients on erlotinib treatment: Written informed consent to participate in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Hypersensitivity to dapsone
研究者
相似试验
已完成
3 期
A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%Acne VulgarisNCT00151541Allergan301
已完成
2 期
Dapson in acne vulgarisIRCT2017072035195N1Rasht University of Medical Sciences60
已完成
2 期
Evaluation of the effectiveness of oral dapsone with intralesional antimoniate in treatment of cutaneous leishmaniasisCutaneous Leishmaniasis.Cutaneous leishmaniasisB55.1IRCT20140211016554N4Mashhad University of Medical Sciences100
招募中
3 期
Effect of Dapsone gel 5% in the treatment of patients with acne vulgarisIRCT20230806059062N1Ahvaz University of Medical Sciences60
终止
4 期
Use of Dapsone Gel, 5% for Treating Dermatitis HerpetiformisDermatitis HerpetiformisNCT01115244Vanderbilt University Medical Center1